Related Experiment Videos
Serum neuron-specific enolase in various pathological conditions.
G Donato1, A Gallelli, L Rivalta
1Cattedra di Neurochirurgia, Università di Reggio Calabria.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|January 1, 1992
Summary
Neuron-specific enolase (NSE) serum levels are not absolute disease markers, especially in patients with combined endocrine, nervous, and pulmonary conditions. This study highlights limitations in using NSE for diagnosing disease origin.
Area of Science:
- Clinical Chemistry
- Neurology
- Pulmonology
Background:
- Neuron-specific enolase (NSE) is a biomarker investigated for various diseases.
- Accurate interpretation of NSE levels is crucial for diagnosis.
Purpose of the Study:
- To quantitatively determine serum NSE levels in neurological and pulmonary disease patients.
- To evaluate the diagnostic specificity of NSE in different disease contexts.
Main Methods:
- Radioimmunoassay (RIA) method was employed for NSE quantification.
- Serum samples were analyzed from 18 patients with neurological disorders and 22 with pulmonary diseases.
Main Results:
- The study found that NSE is not an absolute marker for disease nature or origin.
- Diagnostic challenges arise in patients with co-existing endocrine, nervous, and pulmonary abnormalities.
Conclusions:
- Serum NSE lacks absolute specificity for diagnosing neurological or pulmonary diseases.
- Clinical utility of NSE is limited in complex cases with multiple comorbidities.